147 related articles for article (PubMed ID: 8957240)
41. Placebo-controlled study of the D4/5-HT2A antagonist fananserin in the treatment of schizophrenia.
Truffinet P; Tamminga CA; Fabre LF; Meltzer HY; Rivière ME; Papillon-Downey C
Am J Psychiatry; 1999 Mar; 156(3):419-25. PubMed ID: 10080558
[TBL] [Abstract][Full Text] [Related]
42. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
Nakane M; Cowart MD; Hsieh GC; Miller L; Uchic ME; Chang R; Terranova MA; Donnelly-Roberts DL; Namovic MT; Miller TR; Wetter JM; Marsh K; Stewart AO; Brioni JD; Moreland RB
Neuropharmacology; 2005 Jul; 49(1):112-21. PubMed ID: 15992586
[TBL] [Abstract][Full Text] [Related]
43. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
[TBL] [Abstract][Full Text] [Related]
44. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.
Kesten SR; Heffner TG; Johnson SJ; Pugsley TA; Wright JL; Wise LD
J Med Chem; 1999 Sep; 42(18):3718-25. PubMed ID: 10479303
[TBL] [Abstract][Full Text] [Related]
46. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
Schetz JA; Chu A; Sibley DR
J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
Coldwell MC; Boyfield I; Brown T; Hagan JJ; Middlemiss DN
Br J Pharmacol; 1999 Aug; 127(7):1696-702. PubMed ID: 10455328
[TBL] [Abstract][Full Text] [Related]
48. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
49. Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626.
Bowery BJ; Razzaque Z; Emms F; Patel S; Freedman S; Bristow L; Kulagowski J; Seabrook GR
Br J Pharmacol; 1996 Dec; 119(7):1491-7. PubMed ID: 8968560
[TBL] [Abstract][Full Text] [Related]
50. Dopamine/serotonin receptor ligands. Part IV [1]: synthesis and pharmacology of novel 3-benzazecines and 3-benzazonines as potential 5-HT2A and dopamine receptor ligands.
El-Subbagh H; Wittig T; Decker M; Elz S; Nieger M; Lehmann J
Arch Pharm (Weinheim); 2002 Nov; 335(9):443-8. PubMed ID: 12447918
[TBL] [Abstract][Full Text] [Related]
51. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
[TBL] [Abstract][Full Text] [Related]
52. Identification of a new selective dopamine D4 receptor ligand.
Sampson D; Zhu XY; Eyunni SV; Etukala JR; Ofori E; Bricker B; Lamango NS; Setola V; Roth BL; Ablordeppey SY
Bioorg Med Chem; 2014 Jun; 22(12):3105-14. PubMed ID: 24800940
[TBL] [Abstract][Full Text] [Related]
53. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
54. Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study.
Ricci A; Bronzetti E; Felici L; Tayebati SK; Amenta F
Neurosci Lett; 1997 Jun; 229(2):130-4. PubMed ID: 9223608
[TBL] [Abstract][Full Text] [Related]
55. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K; Liljefors T; Hyttel J; Perregaard J
J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
[TBL] [Abstract][Full Text] [Related]
56. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR
J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944
[TBL] [Abstract][Full Text] [Related]
57. SH3 binding domains in the dopamine D4 receptor.
Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.
Doble A; Girdlestone D; Piot O; Allam D; Betschart J; Boireau A; Dupuy A; Guérémy C; Ménager J; Zundel JL
Br J Pharmacol; 1992 Jan; 105(1):27-36. PubMed ID: 1596688
[TBL] [Abstract][Full Text] [Related]
59. [3H]RP 62203, a ligand of choice to label in vivo brain 5-HT2 receptors.
Fajolles C; Boireau A; Ponchant M; Laduron PM
Eur J Pharmacol; 1992 May; 216(1):53-7. PubMed ID: 1526254
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells.
Coldwell MC; Boyfield I; Brown AM; Stemp G; Middlemiss DN
Br J Pharmacol; 1999 Jul; 127(5):1135-44. PubMed ID: 10455259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
